CD274 and neoplasm: Each of them has a specific scoring system—immune count for SP142, focusing exclusively on the tumor area occupied by PD-L1-expressing tumor-infiltrating immune cells (IC), and Combined Positive Score for 22C3, considering positive expression in both tumor and immune cells (CPS) [34].